Research Paper Volume 16, Issue 2 pp 1712—1732
Malignant cell receptor-ligand subtypes guide the prediction of prognosis and personalized immunotherapy of liver cancer
Figure 6. Immunological characteristics of molecular subtypes and differences in immunotherapy/chemotherapy. (A) The difference of 28 immune cell scores between different molecular subtypes in the TCGA cohort. (B) The difference of ESTIMATE immune infiltration between different molecular subtypes in the TCGA cohort. The immune checkpoint of differential expression between different subgroups in the TCGA cohort. Difference of TIDE analysis results between different groups in TCGA queue.